Showing results (81-90 of 303) with videos related to
Sort By:
Pageof 31
Research Communications in Chemical Pathology and Pharmacology|July 1, 1986
Hydralazine inhibits vascular reactivity by a mechanism independent of vascular prostaglandin biosynthesis: role of thromboxane synthetase in blocking hydralazine actionsA I Ally, D F HorrobinMedical Hypotheses|April 1, 1980
Myotonic dystrophy: a disease caused by functional zinc deficiency due to an abnormal zinc-binding ligand?D F Horrobin, R O MorganLipids|August 1, 1983
How do polyunsaturated fatty acids lower plasma cholesterol levels?D F Horrobin, M S MankuMedical Hypotheses|March 1, 1983
Schizophrenia: the role of abnormal essential fatty acid and prostaglandin metabolismD F Horrobin, Y S HuangBritish Medical Journal|June 7, 1980
Possible role of prostaglandin E1 in the affective disorders and in alcoholismD F Horrobin, M S MankuAdvances in Experimental Medicine and Biology|January 1, 1997
The importance of linoleic acid metabolites in cancer metastasis and in the synthesis and actions of 13-HODED F Horrobin, V A ZibohCanadian Journal of Physiology and Pharmacology|January 1, 1979
Copper inhibits pressor responses to noradrenaline but not potassium. Interactions with prostaglandins E1, E2, and I2 and penicillamineS C Cunnane, H Zinner, D F Horrobin, et al.Medical Hypotheses|October 12, 2002
Treatment of multiple sclerosis with lofepramine, L-phenylalanine and vitamin B(12): mechanism of action and clinical importance: roles of the locus coeruleus and central noradrenergic systemsC Loder, J Allawi, D F HorrobinJournal of Nutritional Science and Vitaminology|December 1, 1991
The effect of maternal supplementation with linoleic and gamma-linolenic acids on the fat composition and content of human milk: a placebo-controlled trialA Cant, J Shay, D F HorrobinSchizophrenia Research|December 1, 1991
Fatty acids in plasma phospholipids and cholesterol esters from identical twins concordant and discordant for schizophreniaC Bates, D F Horrobin, K EllsPageof 31